A Sober Look At This Psychedelic Stock
Amid growing acceptance of the use of psychedelic drugs for treating mental disorders, the clinical-stage biotech company featured in today’s article, which has a pipeline…
A Strong Product Pipeline, Solid Upside And Attractive Valuation Could Make This Biotech A Buy
With nine FDA-approved products and more than 30 product candidates in clinical development – including a potential COVID-19 therapeutic – the biotechnology company featured in…
Even SPAC Skeptics Are Intrigued By This One
While the contributors to today’s article are not necessarily fans of blank check special purpose acquisition companies (SPACs), they cannot help but be intrigued by…
Should These 3 Biotech Stocks Be Excised From Your Portfolio?
When it comes to the three biotech stocks discussed in today’s article, all of which are down 45% or more from their 52-week highs, should…
Biotech Opportunities And Risks In Q2 – And Beyond
After a challenging first quarter of 2021 for biotech investors, what does the second quarter – and, beyond that, the second half of 2021 –…
Select Stocks For The Semiconductor Shortage
There’s a severe shortage of semiconductors – the worst shortage in 30 years according to one analysis – and it’s being felt across many industries,…
How To Approach “Extraordinarily Risky” Clinical-Stage Biotech Stocks
“Investing in any kind of stock can be risky. But investing in clinical-stage biotech stocks can be extraordinarily risky,” acknowledge the authors of today’s article.…
Wall Street Is “Pounding The Table” On This Sector – 5 Picks For Aggressive Investors
“With West Texas Intermediate (WTI) crude trading near the $60 a barrel level, and expected to go even higher this summer, these could all have…
A Stock Screen For Superior Returns With Earnings Yield At The Core
In screening for stocks with the potential of generating solid returns, the author of today’s article uses a high earnings yield as their primary criterion,…
A Focus On Next-Generation Brain Surgery Could Make This Stock A No-Brainer
The company featured in today’s article is creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain – and…